Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas S Griffith

Showing results (41-50 of 179) with videos related to

Pageof 18
Sort By:
Thescientificworldjournal|July 27, 2011
Description of a novel murine model for ileocystoplasty and early histologic changesMatthew R Braasch, Thomas S Griffith, Christopher S Cooper, et al.
Cancer Gene Therapy|August 28, 2004
Inhibition of the NF-kappaB pathway enhances TRAIL-mediated apoptosis in neuroblastoma cellsBahri Karacay, Salih Sanlioglu, Thomas S Griffith, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 18, 2005
Depsipeptide (FR901228) enhances the cytotoxic activity of TRAIL by redistributing TRAIL receptor to membrane lipid raftsRebecca L Vanoosten, Jill M Moore, Aaron T Ludwig, et al.
Journal of Pediatric Surgery|July 26, 2006
Survivin inhibits apoptosis induced by TRAIL, and the ratio between survivin and TRAIL receptors is predictive of recurrent disease in neuroblastomaTakeo Azuhata, David Scott, Thomas S Griffith, et al.
Critical Reviews in Immunology|August 3, 2016
Clinical and Experimental Sepsis Impairs CD8 T-Cell-Mediated ImmunityDerek B Danahy, Robert K Strother, Vladimir P Badovinac, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2019
Cutting Edge: Polymicrobial Sepsis Has the Capacity to Reinvigorate Tumor-Infiltrating CD8 T Cells and Prolong Host SurvivalDerek B Danahy, Isaac J Jensen, Thomas S Griffith, et al.
Journal of Leukocyte Biology|December 8, 2007
TNF-related apoptosis-inducing ligand (TRAIL) is expressed throughout myeloid development, resulting in a broad distribution among neutrophil granulesMark P Simons, Kevin G Leidal, William M Nauseef, et al.
Human Immunology|August 30, 2008
Influenza-induced expression of functional tumor necrosis factor-related apoptosis-inducing ligand on human peripheral blood mononuclear cellsErik L Brincks, Tamara A Kucaba, Kevin L Legge, et al.
Critical Reviews in Immunology|March 21, 2013
T-cell-mediated immunity and the role of TRAIL in sepsis-induced immunosuppressionStephanie A Condotta, Javier Cabrera-Perez, Vladimir P Badovinac, et al.
Cancer Metastasis Reviews|December 8, 2009
The role of neutrophils and TNF-related apoptosis-inducing ligand (TRAIL) in bacillus Calmette-Guérin (BCG) immunotherapy for urothelial carcinoma of the bladderHenry M Rosevear, Andrew J Lightfoot, Michael A O'Donnell, et al.
Pageof 18

Showing results (41-50 of 179) with videos related to

Sort By:
Pageof 18
Thescientificworldjournal|July 27, 2011
Description of a novel murine model for ileocystoplasty and early histologic changesMatthew R Braasch, Thomas S Griffith, Christopher S Cooper, et al.
Cancer Gene Therapy|August 28, 2004
Inhibition of the NF-kappaB pathway enhances TRAIL-mediated apoptosis in neuroblastoma cellsBahri Karacay, Salih Sanlioglu, Thomas S Griffith, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 18, 2005
Depsipeptide (FR901228) enhances the cytotoxic activity of TRAIL by redistributing TRAIL receptor to membrane lipid raftsRebecca L Vanoosten, Jill M Moore, Aaron T Ludwig, et al.
Journal of Pediatric Surgery|July 26, 2006
Survivin inhibits apoptosis induced by TRAIL, and the ratio between survivin and TRAIL receptors is predictive of recurrent disease in neuroblastomaTakeo Azuhata, David Scott, Thomas S Griffith, et al.
Critical Reviews in Immunology|August 3, 2016
Clinical and Experimental Sepsis Impairs CD8 T-Cell-Mediated ImmunityDerek B Danahy, Robert K Strother, Vladimir P Badovinac, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2019
Cutting Edge: Polymicrobial Sepsis Has the Capacity to Reinvigorate Tumor-Infiltrating CD8 T Cells and Prolong Host SurvivalDerek B Danahy, Isaac J Jensen, Thomas S Griffith, et al.
Journal of Leukocyte Biology|December 8, 2007
TNF-related apoptosis-inducing ligand (TRAIL) is expressed throughout myeloid development, resulting in a broad distribution among neutrophil granulesMark P Simons, Kevin G Leidal, William M Nauseef, et al.
Human Immunology|August 30, 2008
Influenza-induced expression of functional tumor necrosis factor-related apoptosis-inducing ligand on human peripheral blood mononuclear cellsErik L Brincks, Tamara A Kucaba, Kevin L Legge, et al.
Critical Reviews in Immunology|March 21, 2013
T-cell-mediated immunity and the role of TRAIL in sepsis-induced immunosuppressionStephanie A Condotta, Javier Cabrera-Perez, Vladimir P Badovinac, et al.
Cancer Metastasis Reviews|December 8, 2009
The role of neutrophils and TNF-related apoptosis-inducing ligand (TRAIL) in bacillus Calmette-Guérin (BCG) immunotherapy for urothelial carcinoma of the bladderHenry M Rosevear, Andrew J Lightfoot, Michael A O'Donnell, et al.
Pageof 18